KLTO - ANEW Medical Uzoq muddatli majburiyatlarning kapitalga nisbati
Klotho Neurosciences Inc ALS va demensiyaga qarshi kurashish uchun Klotho oqsili asosidagi biofarmatsevtika vositalarini ishlab chiqadi. Startap hozirda preklinik sinovlar uchun grantlarni ta'minlash maqsadida akademik hamkorlarni qidirmoqda. Uzoq muddatli qarzning kapitalga nisbati tendentsiyasi moliyaviy barqarorlikni namoyish etadi, bunda 0.00 ko'rsatkichi maqsadli daraja vazifasini o'taydi. Biroq, neyromeditsina sohasida yetakchilik uchun sog'liqni saqlash gigantlari bilan bo'lgan shiddatli raqobat tufayli xavf yuqori bo'lib qolmoqda.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_KLTO_-_Klotho-Neurosciences-Inc_-_Long-Term-Debt-to-Equity-Ratio "KLTO: ANEW Medical, Inc. Uzoq muddatli qarzning kapitalga nisbati 18.09.2024 - 11.03.2026 | 👁️GURU.Markets👁️")
ANEW Medical (KLTO) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Klotho Neurosciences Inc|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ANEW Medical, Inc.|KLTO - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Klotho Neurosciences Inc|KLTO - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Klotho Neurosciences
Kompaniyaning har tomonlama tahlili:anewmeds.com
Qarz yuklamasini nazorat qilish biotexnologik ittifoqlar orqali gen terapiyasini ishlab chiqayotgan Klotho Neurosciences Inc (KLTO) uchun juda muhimdir. Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlarni kapitalga nisbatan bog'laydi. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali investor aktivlarni moliyalashtirish manbasini aniqlaydi. Pasayish tendentsiyasi kreditlarning qaytarilishi yoki kapitalizatsiyaning oshganligini anglatishi mumkin. Bu qimmatbaho neyrofarmatsevtika mahsulotlarini yaratish jarayonida kompaniyaning moliyaviy barqarorligini baholash imkonini beradi.
Klotho Neurosciences Inc kimlar bilan raqobatlashadi
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|CPRX (Catalyst Corp) - Uzoq muddatli majburiyatlarning kapitalga nisbati|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati HRMY|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati AMLX (Amylyx Pharmaceuticals Inc)|TRVI: Uzoq muddatli qarzning o'z kapitaliga nisbati|PRAX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Anavex Life Sciences AVXL|CBLL - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Prothena Corp PRTA|ALEC (Alector) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX (Annexon Inc.)|Uzoq muddatli majburiyatlarning kapitalga nisbati Omeros Corp. (OMER)|Neurogene Inc. (NGNE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACIU (acimmune.com)|VYGR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Neumora NMRA|SCLX (Scilex Holding Co.) - Uzoq muddatli qarzning kapitalga nisbati|Tevogen Bio Inc. (TVGN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ACOG: Uzoq muddatli qarzning o'z kapitaliga nisbati|CGTX (cogrx.com) - Uzoq muddatli qarzning kapitalga nisbati|IKT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SAVA|Assertio Holdings, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati COYA (coyatherapeutics.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati VTGN|Uzoq muddatli qarzdorlikning kapitalga nisbati Ovid Therapeutics Inc OVID|ABOS: Uzoq muddatli qarzning kapitalga nisbati|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|alteritytherapeutics.com - Uzoq muddatli qarzning kapitalga nisbati|Clene (CLNN) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati PEPG (PepGen Inc)|Uzoq muddatli majburiyatlarning kapitalga nisbati JUNS|Uzoq muddatli qarzning o'z kapitaliga nisbati Relmada Therapeutics, Inc. RLMD|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Annovis Bio Inc (ANVS)|Grace Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuro AIFF|NRSN (NeuroSense Therapeutics, Ltd.) - Uzoq muddatli qarzning kapitalga nisbati|RVPH: Uzoq muddatli majburiyatlarning kapitalga nisbati|metaviatx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NeurAxis Inc.|HSDT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Passage Bio Corp|NEUP (Neuphoria Therapeutics Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NERV (minervaneurosciences.com)|ATHA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Addex Therapeutics Ltd. ADXN|ALZN: Uzoq muddatli qarzning kapitalga nisbati|CYCN: Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX: Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA (Pasithea Therapeutics Corp.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics Inc. (ATXI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc.|Uzoq muddatli kreditlarning kapitalga nisbati CARA (Cara Therapeutics Inc)|CHRO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Eliem Therapeutics, Inc. - Uzoq muddatli majburiyatlarning kapitalga nisbati|Intra-Cellular (ITCI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati MRNS|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SAGE|Synaptogenix (SNPX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TRVN (Trevena Inc.)|VIGL: Uzoq muddatli qarzning o'z kapitaliga nisbati|Anew Medical Inc. - Uzoq muddatli majburiyatlarning kapitalga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati